Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Comago

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

OrganoBalance GmbH Announces Substantial Investment - Dr Bernd Wegener to invest in Berlin (Germany) Biotech company
OrganoBalance GmbH Announces Substantial Investment


PRZOOM - /newswire/ - Falkensee, Brandenburg, Germany, 2010/06/17 - Dr Bernd Wegener to invest in Berlin (Germany) Biotech company.

Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


ORGANOBALANCE GmbH Berlin and Bernd Wegener DVM, PhD (Chairman of the Board of the German Federal Association of the Pharmaceutical Industry), have announced the completion of an investment agreement which shall take immediate effect. Aside from detailing a financial commitment, the agreement also foresees an active role for Dr Wegener in a position of responsibility at ORGANOBALANCE.

Dr Wegener's investment (the extent of which, as agreed between the parties, shall not be disclosed), his extensive experience, expertise and numerous contacts within the pharmaceutical and biotech industries, shall substantially promote and shape the continued successful development of ORGANOBALANCE GmbH.

“We are truly delighted that an expert of Dr. Wegener’s immense scientific distinction and experience will join our team at ORGANOBALANCE.” Professor Christine Lang, Managing Director of ORGANOBALANCE, commented on the agreed collaboration. "With his support and commitment, we will be able to pursue our strategy of developing new active substances for the pharmaceutical industry much more rapidly and efficiently than previously planned." Professor Lang went on to explain.

Dr Wegener also envisages excellent prospects for their collaboration, commenting that "With innovative, patentable microorganisms and their active principles, we will be able to develop new diagnostic and therapeutic concepts and procedures particularly for hitherto inadequately treatable indications. I am very much looking forward to working with Professor Lang and ORGANOBALANCE, a leading company in this field, and opening up this as yet untapped potential".


ORGANOBALANCE GmbH ( is a company specialising in strain development and microbiological screening. ORGANOBALANCE taps the potential of beneficial microorganisms, known as specific probiotic cultures, in order to counteract, in a natural way, imbalances in the microflora, thus restoring the microbial equilibrium. In close cooperation with renowned industry partners, ORGANOBALANCE develops new biological products in the fields of pharmaceutics, preventive health care, nutrition and cosmetics. In its development activities the company draws on its own collection of microorganisms suitable for use in foodstuffs as well as its own OASSYS® screening systems. ORGANOBALANCE was founded in 2001 and is based in Berlin (Germany).

About Dr Wegener

Bernd Wegener, DVM, has extensive managerial experience from diverse areas of responsibility in the pharmaceutical industry and relevant associations. After holding positions at Boehringer Ingelheim KG, Degussa Pharmagruppe, Marion Merrell Dow GmbH and Henning Berlin GmbH, he was Founder and Chairman of the Board of the B•R•A•H•M•S Group from 1994 to May 2010.
Dr Wegener is also Chairman of the Board of the German Federal Association of the Pharmaceutical Industry (BPI) as well as being a member of the board of various associations and supervisory boards.

All product and company names mentioned herein are possibly protected, and the property of ORGANOBALANCE GmbH or other companies.

For further information please contact:
Mrs Kristin Ebert
Gustav-Meyer-Allee 25
13355 Berlin, Germany
T: +49 30 46307-200
F: +49 30 46307-210
E: info[.]

Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Comago


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]

# # #
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!

OrganoBalance GmbH Announces Substantial Investment

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Helmut Landenberger - 
+49 33 22 84 06 52 landenberger[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Comago securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Comago / Company Profile

Read Health/Surgery Most Recent Related Press Releases:

Stress Light Therapy Launches Crowd-Funded Campaign on
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division
Apollo eDoc Launched Online Appointment Platform
Digital Health and Point of Care Driving Growth Opportunities in the Rise of Mobile Molecular Diagnostics Says Frost & Sullivan
Aggressive Expansion and Consolidation Strategies Define APAC’s Top Fifty Healthcare Services Companies Finds Frost & Sullivan
Frost & Sullivan Lauds VitreosHealth’s Advanced Predictive Analytics Solution for Providing Accurate Predictive Risk Analyses of a Population’s Health
Less Restrictive Indian Visa to Expand Medical Tourism in the Country According to MedHalt

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...


Visit  Demyk Lightmod Products, Inc.

Visit  MagLar, Inc.

Visit  NAKIVO, Inc.

  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today